Image from Google Jackets

Macular edema : risk factors, treatment options and long-term outcomes [E-Book]

Contributor(s): Series: Eye and Vision Research DevelopmentsPublisher: New York : Nova Publishers, [2014]Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781633216013
  • 1633216012
Subject(s): Online resources:
Contents:
MACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; MACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: MANAGEMENT OF DIABETIC MACULAR EDEMA BY INTRAVITREAL ANTIANGIOGENIC DRUGS; ABSTRACT; INTRODUCTION; ROLE OF VEGF; PEGAPTANIB (MACUGEN�, PFIZER OPHTHALMICS); RANIBIZUMAB (LUCENTIS�, GENENTECH, NOVARTIS); BEVACIZUMAB (AVASTIN�, ROCHE, GENENTECH); AFLIBERCEPT (EYLEA�, BAYER, REGENERON PHARMACEUTICALS); TREATMENT PROTOCOLS; CONCLUSION; REFERENCES.
Chapter 2: MANAGEMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION BY INTRAVITREAL BEVACIZUMABABSTRACT; INTRODUCTION; PATHOGENESIS; TREATMENT; ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR; ANTIANGIOGENIC TREATMENT; INTRAVITREOUS BEVACIZUMAB IN BRVO; INTRAVITREOUS BEVACIZUMAB IN CRVO; ANTI-VEGF IN ISCHEMIC RETINA; TREATMENT PROTOCOLS; CONCLUSION; REFERENCES; Chapter 3: POSTOPERATIVE CYSTOID MACULAR EDEMA IN DIABETIC PATIENTS: PROPHYLAXIS AND MANAGEMENT; ABSTRACT; INTRODUCTION; PATHOGENESIS; PREOPERATIVE CARE; MANAGEMENT; REFERENCES; Chapter 4: MANAGEMENT OF DIABETIC MACULAR EDEMA.
ABSTRACTINTRODUCTION; MANAGEMENT OF SYSTEMIC RISK FACTORS; LASER PHOTOCOAGULATION FOR DME; PHARMACOLOGICAL DME TREATMENT; COMBINATION THERAPY FOR DME MANAGEMENT; SURGICAL TREATMENT OF DME; TREATMENT GUIDELINES OF DME; CONCLUSION; REFERENCES; Chapter 5: CURRENT MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY OF DIABETIC MACULAR OEDEMA; PATHOPHYSIOLOGY OF CHRONIC DIABETIC MACULAR OEDEMA; INVESTIGATIONS FOR DMO; LASER TREATMENT IN THE MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ANTI-VEGF THERAPIES.
INTRAVITREAL STEROIDS TO TREAT CHRONIC DIABETIC MACULAR OEDEMADMO TREATMENT ALGORITHM; FUTURE MANAGEMENT OPTIONS; CONCLUSION; REFERENCES; Chapter 6: MACULAR EDEMA IN IMPORTANT TROPICAL INFECTIONS; ABSTRACT; INTRODUCTION; MACULAR EDEMA IN SOME IMPORTANT TROPICAL INFECTIONS; CONCLUSION; REFERENCES; Chapter 7: CYSTOID MACULAR EDEMA: A DIFFICULT OCULAR DISORDER TO CURE; ABSTRACT; INTRODUCTION; MACULAR HOLE; TREATMENT OF MACULAR EDEMA; CASE REPORT; DISCUSSION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; INDEX.
Summary: Macular edema is a serious eye disorder that can be seen in many conditions. Central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are frequent causes of decreased central visual acuity (VA) related to the appearance of macular edema (ME) and ischemia. This book discusses the risk factors, treatment options and long-term outcomes of macular edema. Some of the topics discussed include the management of diabetic macular edema; management of macular edema secondary to retinal vein occulsion by intravitreal bevacizumab; and macular edema in important tropical infections.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Includes bibliographical references and index.

Description based on print version record and CIP data provided by publisher.

MACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; MACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: MANAGEMENT OF DIABETIC MACULAR EDEMA BY INTRAVITREAL ANTIANGIOGENIC DRUGS; ABSTRACT; INTRODUCTION; ROLE OF VEGF; PEGAPTANIB (MACUGEN�, PFIZER OPHTHALMICS); RANIBIZUMAB (LUCENTIS�, GENENTECH, NOVARTIS); BEVACIZUMAB (AVASTIN�, ROCHE, GENENTECH); AFLIBERCEPT (EYLEA�, BAYER, REGENERON PHARMACEUTICALS); TREATMENT PROTOCOLS; CONCLUSION; REFERENCES.

Chapter 2: MANAGEMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION BY INTRAVITREAL BEVACIZUMABABSTRACT; INTRODUCTION; PATHOGENESIS; TREATMENT; ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR; ANTIANGIOGENIC TREATMENT; INTRAVITREOUS BEVACIZUMAB IN BRVO; INTRAVITREOUS BEVACIZUMAB IN CRVO; ANTI-VEGF IN ISCHEMIC RETINA; TREATMENT PROTOCOLS; CONCLUSION; REFERENCES; Chapter 3: POSTOPERATIVE CYSTOID MACULAR EDEMA IN DIABETIC PATIENTS: PROPHYLAXIS AND MANAGEMENT; ABSTRACT; INTRODUCTION; PATHOGENESIS; PREOPERATIVE CARE; MANAGEMENT; REFERENCES; Chapter 4: MANAGEMENT OF DIABETIC MACULAR EDEMA.

ABSTRACTINTRODUCTION; MANAGEMENT OF SYSTEMIC RISK FACTORS; LASER PHOTOCOAGULATION FOR DME; PHARMACOLOGICAL DME TREATMENT; COMBINATION THERAPY FOR DME MANAGEMENT; SURGICAL TREATMENT OF DME; TREATMENT GUIDELINES OF DME; CONCLUSION; REFERENCES; Chapter 5: CURRENT MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY OF DIABETIC MACULAR OEDEMA; PATHOPHYSIOLOGY OF CHRONIC DIABETIC MACULAR OEDEMA; INVESTIGATIONS FOR DMO; LASER TREATMENT IN THE MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ANTI-VEGF THERAPIES.

INTRAVITREAL STEROIDS TO TREAT CHRONIC DIABETIC MACULAR OEDEMADMO TREATMENT ALGORITHM; FUTURE MANAGEMENT OPTIONS; CONCLUSION; REFERENCES; Chapter 6: MACULAR EDEMA IN IMPORTANT TROPICAL INFECTIONS; ABSTRACT; INTRODUCTION; MACULAR EDEMA IN SOME IMPORTANT TROPICAL INFECTIONS; CONCLUSION; REFERENCES; Chapter 7: CYSTOID MACULAR EDEMA: A DIFFICULT OCULAR DISORDER TO CURE; ABSTRACT; INTRODUCTION; MACULAR HOLE; TREATMENT OF MACULAR EDEMA; CASE REPORT; DISCUSSION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; INDEX.

Macular edema is a serious eye disorder that can be seen in many conditions. Central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are frequent causes of decreased central visual acuity (VA) related to the appearance of macular edema (ME) and ischemia. This book discusses the risk factors, treatment options and long-term outcomes of macular edema. Some of the topics discussed include the management of diabetic macular edema; management of macular edema secondary to retinal vein occulsion by intravitreal bevacizumab; and macular edema in important tropical infections.

WorldCat record variable field(s) change: 650

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice